CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
lifesciencesreview
US
EUROPE
APAC
CANADA
  • US
    • US
    • EUROPE
    • APAC
    • CANADA
    • LATAM
  • Home
  • Contributors
  • News
  • Conferences
  • Newsletter
  • Whitepapers
  • Magazine
×
#

Life Science Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Life Science Review

Subscribe

loading

Thank you for Subscribing to Life Science Review Weekly Brief

  • Home
  • News

Recommended picks

RealTime Software Solutions Acquires Complion

RealTime Software Solutions Acquires...

What role does artificial intelligence play in the employment process?

What role does artificial...

Why AI is Used for Quality Management in Life Science

Why AI is Used for Quality Management...

Application of AI in Genetics

Application of AI in Genetics

How Artificial Intelligence Impacts Biotechnology

How Artificial Intelligence Impacts...

Akanta's Contextual Intelligence 360 to Enhance Customer Experience

Akanta's Contextual Intelligence 360...

MMIT/Evaluate to Boost Pharma Analytics After Acquisition of Panalgo

MMIT/Evaluate to Boost Pharma...

Syneos Health's Acquisition of RxDataScience to Help Boost Product Development

Syneos Health's Acquisition of...

RealTime Software Solutions Acquires Complion

RealTime Software Solutions Acquires...

What role does artificial intelligence play in the employment process?

What role does artificial...

Why AI is Used for Quality Management in Life Science

Why AI is Used for Quality Management...

Application of AI in Genetics

Application of AI in Genetics

How Artificial Intelligence Impacts Biotechnology

How Artificial Intelligence Impacts...

Akanta's Contextual Intelligence 360 to Enhance Customer Experience

Akanta's Contextual Intelligence 360...

MMIT/Evaluate to Boost Pharma Analytics After Acquisition of Panalgo

MMIT/Evaluate to Boost Pharma...

Syneos Health's Acquisition of RxDataScience to Help Boost Product Development

Syneos Health's Acquisition of...

Three Strategies Life Sciences Industry Can Implement for AI-related IP Protection

Life Sciences Review | Thursday, August 12, 2021
Tweet

Life sciences industry must adopt strategies for IP protection to define, claim and safeguard their innovations.


FREMONT, CA: Artificial intelligence (AI) is a fast-growing area of the life sciences industry, with associations in drug development, biotechnology, medical diagnosis, clinical trials, precision and customized medicine, and patient monitoring. The wide availability of "big data" is likely to be responsible for increasing AI use in this area. Machine learning, deep learning, and natural language processing are examples of AI technologies that can be used to prepare large data sets to discover novel medication candidates, refine drug dosage, recognize suitable patients for drug trials, and diagnose diseases.


Life sciences organizations must take specific actions for their AI-related IP protection.


Contractually defined IP rights


Life science firms that use AI can avoid IP ownership challenges by establishing who owns AI-related IP rights in employment, licensing, or purchase agreements. Such agreements must also state who will control the data, information, or outcomes produced by AI, who will be able to use it, and how they will be utilized.


Putting AI inventions under trade secret protection


Aside from typical contractual IP safeguards, life sciences businesses should consider what kind of IP protection is appropriate for their AI-related inventions. In comparison to standard patent protection, trade secret protection can be advantageous. However, companies using this approach should be aware that trade secret protection is only maintained if the owner takes "reasonable means" to keep the information secret. .


Given the enormous number of people involved in discovery, product development, regulatory, and manufacturing operations, this demand for confidentiality may be challenging for life sciences organizations to meet. Thus, companies should take appropriate safety measures


Inventorship: Any possible inventorship dispute can be avoided by preparing patent applications so that human inventors are required. For example, patent applications can be drafted to describe human input in AI systems' design, training, and execution, and patent claims can be drafted to include human actions and processes.


Acquire a Patenting AI Playbook: Companies must follow the steps in the "AI-Patent Playbook" to seek patent protection for AI-related ideas as follows.


Enablement and Written Description Challenges: Patentees must provide enough information about their invention available to the public so that someone with ordinary competence in the art can visualize and practice the claimed invention. When AI has aided in identifying vast genera of substances or when the AI approach is stated to include extensive "black box" computer programming, meeting such standards can be difficult. Practitioners should give as much detail as feasible in describing the claimed inventions when making claims using machine learning or deep learning.


Subject matter eligibility: Patent practitioners should take action today to reduce the likelihood of future AI-related life science claims being rejected or invalidated. One strategy is to write claims that apply the AI's abstract idea or mental process in a specific or unusual way to get a practical result.


See Also: Top API Companies


Weekly Brief

loading
> <
  • Regulatory Services 2023

    Top Vendors

    Current Issue
  • Clinical Lab Equipment 2023

    Top Vendors

    Current Issue
  • Regulatory Services 2023

    Top Vendors

    Current Issue
  • Clinical Lab Equipment 2023

    Top Vendors

    Current Issue

Read Also

Prophesying DNA Sequencing for 2023

Crucial Workflows of Next-Generation Sequencing

An Overview of Next-Generation Sequencing

The Role of AI in Accurate Medical Writing

Patrik Renblad to Join Cantargia as Chief Financial Officer

Overview of the Life Sciences BPO Market

Dr. Zamaneh Mikhak Joins TFF Pharmaceutical as the New Chief Medical Officer

The Significance of AI in Medical Writing

Loading...

Copyright © 2023 Life Sciences Review . All rights reserved. |  Subscribe |  About Us follow on linkedin

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://www.lifesciencesreview.com/news/three-strategies-life-sciences-industry-can-implement-for-airelated-ip-protection--nwid-496.html